124
Participants
Start Date
March 19, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
May 31, 2026
Placebo intramuscular injection
On the basis of background treatment, intramuscular injection of placebo was added.
Human interleukin-2 (I) intramuscular injection
On the basis of background treatment, intramuscular injection of human interleukin-2 (I) will be added.
RECRUITING
the Second Xiangya Hospital of Central South University, Changsha
Xiangya Hospital of Central South University
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Tongji Hospital
OTHER
West China Hospital
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Fujian Medical University Union Hospital
OTHER
Second Affiliated Hospital of Guangzhou Medical University
OTHER
The First People's Hospital of Changde City
OTHER
The Third People's Hospital of Hangzhou
OTHER
Second Xiangya Hospital of Central South University
OTHER